Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC

NCT03672305 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Primary Hepatocellular Carcinoma

Interventions

BIOLOGICAL: c-Met/PD-L1 CAR-T cell injection

Sponsor

The Second Hospital of Nanjing Medical University